Pfizer (FRA:PFEB) E10: €0.77 (As of Mar. 2026)


FRA:PFEB Pfizer Inc FRA:PFEB
74 GF Score
Price €6.55
GF Value €7.03
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer E10?

Pfizer FRA:PFEB -0.76% 74 E10 is €0.77 as of Mar. 2026. GuruFocus rates FRA:PFEB with a GF Score™ of 74/100 and a GF Value™ of €7.03 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.138. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pfizer's average E10 Growth Rate was 2.20% per year. During the past 3 years, the average E10 Growth Rate was -2.00% per year. During the past 5 years, the average E10 Growth Rate was 4.40% per year. During the past 10 years, the average E10 Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pfizer was 20.10% per year. The lowest was -4.10% per year. And the median was 8.30% per year.

As of today (2026-06-27), Pfizer's current stock price is €6.55. Pfizer's E10 for the quarter that ended in Mar. 2026 was €0.77. Pfizer's Shiller PE Ratio of today is 8.51.

During the past 13 years, the highest Shiller PE Ratio of Pfizer was 24.28. The lowest was 7.88. And the median was 17.03.


Pfizer  (FRA:PFEB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.55/0.77
=8.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pfizer was 24.28. The lowest was 7.88. And the median was 17.03.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pfizer E10 Related Terms


Pfizer E10 Historical Data

* Premium members only.

The historical data trend for Pfizer's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer E10 Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.97 0.86 0.82 0.76

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.77 0.71 0.76 0.77

FRA:PFEB vs GILD, BMY, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.


FRA:PFEB
74GF Score
Pfizer Inc FRA:PFEB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.138/330.2130*330.2130
=0.138

Current CPI (Mar. 2026) = 330.2130.

Pfizer Quarterly Data

per share eps CPI Adj_EPS
201606 0.100 241.018 0.137
201609 0.067 241.428 0.092
201612 0.042 241.432 0.057
201703 0.162 243.801 0.219
201706 0.154 244.955 0.208
201709 0.134 246.819 0.179
201712 0.580 246.524 0.777
201803 0.162 249.554 0.214
201806 0.189 251.989 0.248
201809 0.201 252.439 0.263
201812 -0.021 251.233 -0.028
201903 0.204 254.202 0.265
201906 0.267 256.143 0.344
201909 0.419 256.759 0.539
201912 -0.018 256.974 -0.023
202003 0.184 258.115 0.235
202006 0.187 257.797 0.240
202009 0.075 260.280 0.095
202012 0.028 260.474 0.035
202103 0.245 264.877 0.305
202106 0.276 271.696 0.335
202109 0.410 274.310 0.494
202112 0.177 278.802 0.210
202203 0.422 287.504 0.485
202206 0.556 296.311 0.620
202209 0.518 296.808 0.576
202212 0.279 296.797 0.310
202303 0.308 301.836 0.337
202306 0.129 305.109 0.140
202309 -0.134 307.789 -0.144
202312 -0.187 306.746 -0.201
202403 0.172 312.332 0.182
202406 0.003 314.175 0.003
202409 0.239 315.301 0.250
202412 0.023 315.605 0.024
202503 0.163 319.799 0.168
202506 0.150 322.561 0.154
202509 0.179 324.800 0.182
202512 -0.084 324.054 -0.086
202603 0.138 330.213 0.138

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.77 mean?
Pfizer (FRA:PFEB) has a E10 of €0.77 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's E10 too high?
Pfizer's current E10 is €0.77. Overall, Pfizer has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's E10 compare to GILD and BMY?
Pfizer's E10 of €0.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current E10 is €0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (FRA:PFEB) is currently considered Fairly Valued. The stock's GF Value™ is €7.03, compared to a current price of €6.55 — trading 6.8% below its estimated fair value. The current E10 is €0.77. Pfizer's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pfizer (FRA:PFEB), the current E10 is €0.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (FRA:PFEB) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of €6.55 is trading 6.8% below its estimated GF Value™ of €7.03. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for FRA:PFEB:

  • E10: €0.77
  • GF Value™: €7.03 vs. price of €6.55 (6.8% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the FRA:PFEB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
74GF Score

Get the complete analysis for FRA:PFEB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.55
Price
€7.03
GF Value